Finance News

After the vote on the Budget, the dollar goes down

After the vote on the Budget, the dollar goes down

The market received the average sanction of the Budget approved this Thursday at dawn, a key step for the agreement with the Monetary Fund, with a dollar in decline. After two days of rise, the currency traded at $ 37.70 at Banco Nación (always the cheapest), 17 cents more than […]

Primary public spending goes 14 points behind inflation

Primary public spending goes 14 points behind inflation

With a year-on-year inflation of 40.5%, the Ministry of Finance informed that in September the primary expenses that do not include interest increased 26.5% in relation to a year ago. This reduction in real spending – of 14 points – is mainly explained by the drop in social benefits, which […]

The IMF approved the plan and sends US $ 24,000 million to face the recession

The IMF approved the plan and sends US $ 24,000 million to face the recession

The Executive Board of the International Monetary Fund (IMF) approved yesterday in Washington the renewed stand-by agreement that will grant a total of 56,300 million dollars for Argentina and that accelerates the disbursement of some 24,000 million dollars that the Government may have in the next 6 months, when a […]

x

The Government studies potential cartelization cases

The National Commission for the Defense of Competition (CNDC) initiated market research on medicines, fuels and cement to identify possible distorting practices that imply inappropriately high prices in those sectors. Under the rule of a new law, which creates the figure of “repentant” in cases of cartelization, the body also […]

HCR Wealth Advisors Acquires 1,081 Shares of Charles Schwab Co. (SCHW)

HCR Wealth Advisors Acquires 1,081 Shares of Charles Schwab Co. (SCHW)

HCR Wealth Advisors increased its holdings in Charles Schwab Co. (NYSE:SCHW) by 2.9% in the third quarter, HoldingsChannel reports. The firm owned 38,224 shares of the financial services provider’s stock after purchasing an additional 1,081 shares during the period. HCR Wealth Advisors’ holdings in Charles Schwab were worth $1,730,000 as of its […]

Dancing with taxes on the deck of the Titanic

Dancing with taxes on the deck of the Titanic

Taxes, throughout history, have been the cause of revolutions and rebellions to a greater extent than ideologies. To cite the most emblematic examples, it is worth recalling the tea tax in the causes of the independence of the United States or the tax on bread, one of the important triggers […]

Howden Joinery Group Plc (HWDN) Insider Buys £13,860 in Stock

Howden Joinery Group Plc (HWDN) Insider Buys £13,860 in Stock

Howden Joinery Group Plc (LON:HWDN) insider Karen Caddick bought 3,000 shares of the company’s stock in a transaction on Friday, November 16th. The shares were acquired at an average cost of GBX 462 ($6.04) per share, for a total transaction of £13,860 ($18,110.54).

Celgene Co. (CELG) Shares Bought by HCR Wealth Advisors

Celgene Co. (CELG) Shares Bought by HCR Wealth Advisors

HCR Wealth Advisors lifted its position in Celgene Co. (NASDAQ:CELG) by 7.4% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 11,949 shares of the biopharmaceutical company’s stock after purchasing an additional 824 shares during the […]

Comparing Greif (GEF.B) and Sonoco Products (SON)

Comparing Greif (GEF.B) and Sonoco Products (SON)

Greif (NYSE:GEF.B) and Sonoco Products (NYSE:SON) are both mid-cap industrial products companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, profitability, valuation, risk, earnings and dividends. Volatility & Risk Greif has a beta of 1.14, suggesting […]

Theravance Biopharma’s (TBPH) “Strong-Buy” Rating Reaffirmed at Zacks Investment Research

Theravance Biopharma’s (TBPH) “Strong-Buy” Rating Reaffirmed at Zacks Investment Research

Zacks Investment Research reaffirmed their strong-buy rating on shares of Theravance Biopharma (NASDAQ:TBPH) in a research note issued to investors on Friday morning. They currently have a $29.00 target price on the biopharmaceutical company’s stock.